ReAlta Life Sciences

Norfolk, VA · Privately Held (backing)

Developer of immunomodulatory therapeutics designed for the treatment of acute inflammatory and rare diseases. ReAlta Life Sciences is based in Norfolk, VA. It was valued at $230 million at its later-stage round in Apr 2026, the last priced event on record. It has raised $155 million across 5 recorded rounds; the latest was a $25 million early-stage round in Dec 2024.

PMV mark · valuation
$230.0M
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$155.4M
Last round
Early Stage VC
Dec 2024

Who backs ReAlta Life Sciences?

12 investors
InvestorType
Virginia Innovation Partnership CorporationVenture capital
Children's Research Holdings—
Cock Island Capital—
Cystic Fibrosis Foundation—
Eriko Life Science Ventures—
Koa Labs—
Lung—
Marathon Pharmaceuticals—
National Heart—
National Institute Of Allergy and Infectious Diseases—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ReAlta Life Sciences investors

12 investors are on record for ReAlta Life Sciences, including Virginia Innovation Partnership Corporation, Children's Research Holdings, Cock Island Capital and Cystic Fibrosis Foundation. The early-stage round in Dec 2024 drew 109 investors.

Free account
More of ReAlta Life Sciences with a free account
  • ·The complete investor list: 12 names
  • ·Watch ReAlta Life Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like ReAlta Life Sciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View